《大行报告》高盛将永升生活服务(01995.HK)纳入确信买入名单 目标价25元
高盛发表研究报告指,永升生活服务(01995.HK)的股价自今年1月高位调整约27%,较其他物管股平均回落17%,幅度更大,令其估值降至与同业相若水平。鉴於永升生活服务的竞争优势和持续高於同业的盈利质素,认为股价回调幅度不合理,现价提供了吸纳良机。
报告指出,物管行业的第三方项目及并购竞争加剧,预期永升生活在第三方项目的资源将有助提升市场份额,同时母企旭辉(00884.HK)亦可为公司未来发展带来更多支持。
高盛提到,永升生活数字化平台将带动增值服务发展,预期智能社区业务利润空间可观,料成为未来主要增长动力,予目标价25元,重申「买入」评级,并列入确信买入名单。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.